Skip to main content

Table 3 Subgroup analysis assessing the association between SHR and in-hospital mortality through odds ratios

From: Prognostic significance of the stress hyperglycemia ratio in critically ill patients

Subgroups

Groups divided by SHR

P for interaction

< 0.50

0.50–0.74

0.75–0.99

1.00–1.24

1.25–1.49

1.50–1.75

≥ 1.75

Age

       

0.253

 ≥ 65

2.13 (1.23–3.67)

1.32 (0.94–1.85)

Ref

1.60 (1.21–2.11)

2.31 (1.69–3.15)

2.50 (1.72–3.63)

2.95 (2.07–4.19)

 

 < 65

2.46 (0.90–6.76)

1.51 (0.65–3.49)

Ref

1.76 (0.92–3.36)

2.12 (0.96–4.64)

2.27 (0.85–6.08)

4.30 (2.13–8.66)

 

Sex

       

0.119

 Male

2.57 (1.39–4.77)

1.47 (0.96–2.26)

Ref

1.82 (1.29–2.57)

2.88 (1.96–4.23)

3.14 (1.96–5.05)

4.09 (2.75–6.16)

 

 Female

1.82 (0.85–3.88)

1.17 (0.74–1.87)

Ref

1.36 (0.93–1.99)

1.74 (1.12–2.71)

1.90 (1.13–3.19)

2.44 (1.49–3.98)

 

DM

       

0.002

 Yes

1.62 (0.98–2.69)

0.99 (0.68–1.45)

Ref

1.11 (0.79–1.55)

1.54 (1.06–2.23)

1.78 (1.18–2.69)

2.22 (1.53–3.21)

 

 No

10.7 (1.65–68.9)

1.72 (0.98–3.03)

Ref

2.49 (1.69–3.66)

3.77 (2.38–5.96)

4.44 (2.32–8.50)

6.56 (3.63–11.9)

 

Hypertension

       

0.341

 Yes

2.25 (1.23–4.11)

1.48 (1.01–2.17)

Ref

1.75 (1.29–2.38)

2.39 (1.68–3.39)

2.82 (1.87–4.25)

3.71 (2.56–5.36)

 

 No

2.27 (1.03–4.99)

1.09 (0.62–1.90)

Ref

1.35 (0.85–2.15)

2.09 (1.25–3.49)

2.13 (1.08–4.18)

2.52 (1.39–4.54)

 

AMI

       

0.891

 Yes

1.44 (0.48–4.27)

0.67 (0.29–1.55)

Ref

0.85 (0.44–1.64)

1.47 (0.73–2.98)

1.66 (0.78–3.52)

2.12 (1.12–4.02)

 

 No

2.45 (1.44–4.16)

1.46 (1.04–2.05)

Ref

1.74 (1.32–2.29)

2.36 (1.72–3.25)

2.62 (1.76–3.90)

3.32 (2.30–4.79)

 

CKD

       

0.015

 Yes

1.80 (1.03–3.14)

0.99 (0.65–1.50)

Ref

1.27 (0.88–1.82)

1.58 (1.03–2.40)

1.70 (1.05–2.73)

2.26 (1.46–3.48)

 

 No

2.60 (0.98–6.90)

1.78 (1.09–2.89)

Ref

1.98 (1.37–2.84)

3.12 (2.09–4.66)

3.66 (2.19–6.10)

4.77 (3.03–7.49)

 

Vasopressor

       

0.019

 Yes

2.91 (1.55–5.46)

1.42 (0.94–2.14)

Ref

1.69 (1.20–2.36)

2.20 (1.50–3.22)

3.35 (2.15–5.21)

4.64 (3.13–6.89)

 

 No

1.60 (0.75–3.41)

1.14 (0.70–1.86)

Ref

1.44 (0.97–2.12)

2.33 (1.50–3.62)

1.59 (0.87–2.88)

1.84 (1.07–3.16)

 

MV

       

0.104

 Yes

1.59 (0.75–3.36)

1.38 (0.88–2.18)

Ref

1.45 (0.97–2.16)

1.96 (1.24–3.10)

1.64 (0.93–2.92)

1.84 (1.08–3.13)

 

 No

2.82 (1.52–5.34)

1.19 (0.76–1.86)

Ref

1.75 (1.25–2.43)

2.49 (1.72–3.62)

3.15 (2.02–4.91)

4.64 (3.14–6.86)

 
  1. The abbreviations are as same as Table 1
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840